The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.
Fiza Shaukat is a native of Pakistan living in the United States. As a biomedical engineer, she was eager to improve her country’s medical devices and digital health strategies. She approached us in ...
PHOENIX, Sept. 19, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative ...
Medical professionals don’t pursue careers in healthcare out of a love of data entry, but it’s an inescapable daily reality for most, taking time away from focused care and consultations with patients ...
Platform as a service allows the health-care industry to access, develop, and run applications on a single platform, reducing the use of resources needed to drive transformation. Provided bySiemens ...
Nexalin Technology announces the shipment of HALO™ Clarity devices to UCSD for a clinical trial on mTBI and PTSD treatment. Nexalin Technology, Inc. has announced that the University of California, ...
Digital pathology allows pathologists to interpret samples remotely from any location, provided there are pathology laboratories to process and digitize glass slides; this reduces risk and maintains ...
Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain ...
HORSHAM, Pa.--(BUSINESS WIRE)--Clinical Ink, a global clinical trial technology company, today announced its acquisition by GI Partners, a leading private equity investment firm. Existing investor ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果